Should you buy SBI, ITC, Divis, Paytm, Bank of Baroda, IndiGo shares now?

Most brokerages are bullish on large ap stocks such as ITC, SBI, Divi's Lab as well as on stocks from broader markets like BoB, IndiGo, Paytm among others.

Image Source: Pixabay

ITC, SBI and Divi's Laboratories each won a thumbs up from brokerages with their healthy set of results for the quarter ended December 2022. They are also positive on Paytm, Bank of Baroda and IndiGo among companies their reported their earnings last week.

Here's what brokerages make of some of the top stocks in focus on February 6:

ITC shares

Brokerages are upbeat on cigarettes-to-hotels conglomerate ITC after the company's strong earnings. Morgan Stanley and JPMorgan have maintained an ‘overweight’ rating on the stock.

TRENDING NOW

ITC's strong results and positive implications from the Union Budget augur well for the stock, according to Morgan Stanley.

Brokerage	Rating	Target price
CLSA	Outperform	Rs 415
Morgan Stanley	Overweight	Rs 415
JPMorgan	Overweight	Rs 425
Jefferies	Buy	Rs 450
Citi	Buy	Rs 425
Nomura	Buy	Rs 445

SBI shares

State Bank of India (SBI), the country's largest lender by assets, reported a strong set of results on Friday that was better than the estimates of most brokerages.

Brokerage	Rating	Target price
CLSA	Buy	Rs 725
Morgan Stanley	Overweight	Rs 715
JP Morgan	Overweight	Rs 720
Goldman Sachs	Buy	Rs 788
Citi	Buy	Rs 700
Macquarie	Outperform	Rs 695
Jeffieries	Buy	Rs 760

Divis Labs shares

Brokerage	Rating	Target price
Morgan Stanley	Underweight	Rs 2,766
Goldman Sachs	Buy	Rs 3,375
Jeffieries	Underperform	Rs 2,550

Bank of Baroda shares

Brokerage	Rating	Target price
CLSA	Outperform	Rs 210
JP Morgan	Overweight	Rs 220
Morgan Stanley	Overweight	Rs 220
Citi	Buy	Rs 188
HSBC	Buy	Rs 228

Interglobe Aviation (IndiGo) shares

Brokerage	Rating	Target price
UBS	Buy	Rs 2,550
JP Morgan	Overweight	Rs 2,400
Goldman Sachs	Buy	Rs 2,360
Citi	Sell	Rs 1,950

Paytm shares

Brokerages are upbeat on Paytm after the release of the digital payments company's financial results. CLSA, Goldman Sachs and CITI each have a ‘buy’ call on the stock.